Clinical Outcomes in Patients With Psoriasis Following Discontinuation of Efalizumab Due to Suspension of Marketing Authorization

Statistics

Original article

Evolución clínica de los pacientes psoriásicos tratados con efalizumab al suspender el fármaco

O. Baniandrés

Corresponding author

ofelia_baniandres@yahoo.es

Corresponding author.

, A. Pulido, C. Silvente, R. Suárez, P. Lázaro

Servicio de Dermatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Read

5840

Times
was read the article

2521

Total PDF

3319

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/S1578-2190(10)70665-X

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	69	17	86
2024 November	84	53	137
2024 October	61	40	101
2024 September	51	28	79
2024 August	93	53	146
2024 July	57	39	96
2024 June	68	40	108
2024 May	49	32	81
2024 April	50	27	77
2024 March	46	34	80
2024 February	46	37	83
2024 January	45	40	85
2023 December	51	33	84
2023 November	52	26	78
2023 October	44	33	77
2023 September	54	26	80
2023 August	28	22	50
2023 July	64	63	127
2023 June	59	30	89
2023 May	45	25	70
2023 April	31	34	65
2023 March	27	14	41
2023 February	23	18	41
2023 January	27	27	54
2022 December	33	44	77
2022 November	15	23	38
2022 October	18	19	37
2022 September	14	40	54
2022 August	17	42	59
2022 July	15	34	49
2022 June	14	27	41
2022 May	20	39	59
2022 April	28	39	67
2022 March	26	58	84
2022 February	19	22	41
2022 January	27	47	74
2021 December	28	39	67
2021 November	25	45	70
2021 October	24	59	83
2021 September	28	48	76
2021 August	14	23	37
2021 July	20	37	57
2021 June	24	23	47
2021 May	23	33	56
2021 April	40	48	88
2021 March	51	30	81
2021 February	41	26	67
2021 January	22	13	35
2020 December	20	17	37
2020 November	28	21	49
2020 October	18	8	26
2020 September	30	7	37
2020 August	21	33	54
2020 July	13	8	21
2020 June	21	22	43
2020 May	26	19	45
2020 April	25	19	44
2020 March	25	20	45
2020 February	3	3	6
2020 January	0	5	5
2019 December	0	6	6
2019 November	0	5	5
2019 October	0	3	3
2019 August	0	4	4
2019 July	0	2	2
2019 June	0	2	2
2019 May	1	36	37
2019 April	0	2	2
2019 March	0	24	24
2019 February	0	3	3
2018 March	0	2	2
2018 February	12	2	14
2018 January	16	5	21
2017 December	12	6	18
2017 November	14	5	19
2017 October	15	7	22
2017 September	13	8	21
2017 August	16	7	23
2017 July	15	0	15
2017 June	39	5	44
2017 May	17	7	24
2017 April	12	15	27
2017 March	17	8	25
2017 February	19	8	27
2017 January	8	4	12
2016 December	21	8	29
2016 November	17	6	23
2016 October	21	5	26
2016 September	31	8	39
2016 August	29	6	35
2016 July	31	7	38
2016 June	13	7	20
2016 May	9	7	16
2016 April	3	1	4
2016 March	6	0	6
2016 February	5	2	7
2016 January	9	5	14
2015 December	8	1	9
2015 November	7	0	7
2015 October	11	3	14
2015 September	12	0	12
2015 August	20	3	23
2015 July	38	4	42
2015 June	25	9	34
2015 May	50	14	64
2015 April	29	4	33
2015 March	27	7	34
2015 February	26	11	37
2015 January	11	12	23
2014 December	23	24	47
2014 November	14	10	24
2014 October	21	16	37
2014 September	16	11	27
2014 August	36	17	53
2014 July	27	18	45
2014 June	38	10	48
2014 May	33	10	43
2014 April	38	6	44
2014 March	37	14	51
2014 February	26	12	38
2014 January	31	16	47
2013 December	31	9	40
2013 November	27	12	39
2013 October	26	15	41
2013 September	33	11	44
2013 August	15	24	39
2013 July	30	52	82
2013 June	20	27	47
2013 May	23	18	41
2013 April	19	21	40
2013 March	20	18	38
2013 February	10	13	23

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter